diagnosed GPA patients. Renal biopsies from these patients, taken at the same time, however, did not show immune complexes [10] . Subsequently, a study from Haas and Eustace [11] was published, reporting electron dense deposits in more than half of renal biopsies from patients with AAV. Also, Neumann et al. [12] found electron dense deposits in a subset of renal biopsies from patients with AAV.
We wondered whether immune complex formation results in complement activation in ANCA-associated glomerulonephritis. In order to answer this question, we analysed histological, immunohistochemical and ultrastructural features in a large cohort of AAV patients with renal biopsies from our Limburg Renal Registry [13] .
M A T E R I A L S A N D M E T H O D S
All patients either positive for PR3-ANCA or for MPO-ANCA in the Limburg Renal Registry [13] [14] [15] were identified between the 1 January 1979 and the 31 August 2011. Patients had undergone a diagnostic renal biopsy for the presence of erythrocyturia, proteinuria and/or an elevation of serum creatinine. Only patients with necrotizing and/or crescentic glomerulonephritis were included. Exclusion criteria were the presence of anti-glomerular basement membrane (GBM) antibodies, concurrent renal disease (such as thin basement membrane nephropathy [14] and/or diabetic nephropathy [16] ) and/or less than five glomeruli in the renal biopsy. From all patients, sufficient (>5 glomeruli per two micron section) material was obtained. One specimen was processed and stained for light microscopy and electron microscopy as previously described [15] . A second specimen was snap frozen in liquid nitrogen and processed for immunohistochemistry. The remaining tissue was stored at À80 C. Renal biopsies were scored independently and blinded from clinical information by two observers (P.v.B.V. and M.H.). When no agreement was reached between the two observers, interpretation was resolved with a third observer (P.v.P.). Per biopsy, at least five levels of (2 lm) section were analysed. Biopsies were classified using the AGN classification [13, 17] into four groups: focal (>50% glomeruli on the slide appear normal), crescentic (>50% of glomeruli contain cellular crescents), sclerotic (>50% of glomeruli are sclerotic) and mixed (biopsy that does not fit within the other groups). In addition, the percentage of normal glomeruli, the percentage of glomeruli containing cellular crescents, the percentage of glomeruli containing fibrinoid necrosis and the percentage of obliterated (sclerosed) glomeruli were documented.
ANCA was measured by indirect immunofluorescence (IF), and by enzyme-linked immunosorbent assay (ELISA) testing, as previously described [18] .
Immunofluorescence
For all stainings, a renal biopsy showing normal renal tissue and checked for the absence of minimal change disease was used as a negative control. On frozen sections, antibodies against IgA 1 (Nordic, Susteren, The Netherlands), IgG (ICN Biomedicals, Irvine, CA), IgM (Sanquin, Amsterdam, The Netherlands), C1q (home-made [19] ), C3c, j and k (Dako, Heverlee, Belgium) were used on the day of renal biopsy. Anti-C3 antibodies, anti-C1q antibodies, anti-j and anti-k antibodies had been labelled directly with fluorescein isothiocyanate (FITC). All the other antibodies were detected using a secondary antibody labelled with FITC (Supplementary Table 1) . Renal biopsies were considered positive for IF when glomerular staining showed a trace or higher of the stained immunoglobulin or complement component on the following scale: 0, trace, 1þ, 2þ, 3þ and 4þ.
Additional IF was performed on frozen sections. For C4d, 2-lm frozen sections were washed three times with phosphate buffered saline (PBS) before incubation with monoclonal mouse anti-human C4d (Quidel, Alkmaar, The Netherlands; 1/200) during 30 min. After three washes, the sections were incubated for 30 min with a FITC-labelled IgG rabbit anti-mouse secondary antibody (1/60). The sections were washed three times and covered with vectashield (Vector Laboratories, Peterborough, UK). For C5b-C9, the same procedure was performed but with mouse anti-human C5b-C9 (Quidel; 1/150) as a primary antibody. As a positive control for C4d and C5b-9, a section from a patient with systemic lupus erythematosus nephritis was included. Renal biopsies were considered C4d and/or C5b-9 positive when glomerular staining was scored 1þ or higher on a scale of 0-4þ. For properdin, the same procedure described above was followed with mouse anti-human properdin (Biotrend Chemicals, Germany; 1/50) as a primary antibody. For mannose-binding lectin, the same procedure was followed with mouse anti-human MBL (Abcam, Cambridge, UK; 1/20). For both properdin and MBL, a renal biopsy from a patient with IgA nephropathy served as a positive control.
Immunohistochemistry
C3d (Dako) was visualized with immunohistochemistry on paraffin sections. For C3d, 4 lm sections were deparaffinized for 3 h at 56 C, rehydrated in PBS and blocked during 10 min with 3% H 2 O 2 . After three washes with PBS, sections were cooked for 3 min in citrate buffer for antibody retrieval (pH 6.0) and left to cool down to room temperature for 1 h. After three washes with PBS, the sections were blocked for 30 min with goat serum (1/50). Next, the slides were incubated overnight at 4 C with polyclonal rabbit anti-human C3d (1/1000). The next morning, sections were washed three times with PBS and incubated for 2 h at room temperature with horseradish peroxidaselabelled Envision anti-rabbit antibody (Dako). Sections were washed three times in PBS and incubated 5-10 min with 3,3 0 -diaminobenzidine. The reaction was stopped by washing with distilled demineralized water for 10 min. Next, sections were counterstained for 10 min with haematoxylin, dehydrated and covered with Entallan (Merck Millipore, UK). As a positive control for C3d, a renal biopsy from a patient diagnosed with membranous nephropathy was included.
C3d was scored on a scale from 0 to 4þ and considered positive when 1þ or higher.
Electron microscopy
For electron microscopy, fresh renal tissue was fixed in 2.5% glutaraldehyde during 24 h and subsequently embedded in Epon. A glomerulus was located and cut in 70 nm slices with an C o m p l e m e n t i n A G N
ultramicrotome and a diamond knife. The slices were stained with uranylacetate (Biorad, Veenendaal, The Netherlands) and lead citrate (BDH, Amsterdam, the Netherlands). Next, the slices were examined with a transmission electron microscope. Consecutive biopsies were included from January 2007 to December 2011.
C3 allotypes
C3 allotypes were determined in patients from whom DNA was available from buffy coats, as previously described [20] . Two alleles, C3S and C3F, result in three phenotypes: C3S, C3FS and C3F. Briefly, a C3 gene fragment was amplified using the following primers: sense 5 0 -ATCCCAGCCAACAGGGAG-3 0 and anti-sense 5 0 -TAGCAGCTTGTGGTTGAC-3 0 , as described previously [21] . The following polymerase chain reaction (PCR) programme was used on a Biometra T3000 (Göttingen, Germany) thermocycler: denaturation at 94 C for 1 min, annealing at 60 C for 1 min and extension at 72 C for 1 min; all for 30 cycles. The last extension period was prolonged to 15 min. PCR products were cleaved with Hin61 (Fermentas, Vilnius, Lithuania) and loaded on a 2.0% agarose gel for electrophoresis.
Circulating immune complexes
Circulating immune complexes (CICx) were determined with a solid-phase anti-human C3b immune complex assay as previously described [22] . Briefly, 2.5 mg of polyclonal goat F(ab)2 anti-human C3 in 100 mL bicarbonate buffer (0.01 M pH 9.6) was coated on a microtitre plate and dried under vacuum overnight. The microtitre plate was then incubated with 100 mL of test serum (diluted 1:10 in Tris buffer containing 10 mM TRIS, 150 mM NaCl, 0.5% Tween-20, 1% bovine serum albumin and 10 mM ethylenediaminetetraacetic acid) at 37 C for 60 min. Aggregated IgG was serially diluted in pooled human serum to obtain concentrations of 200 lg to 3 lg aggregates per mL, then incubated for 30 min at 37 C in a water bath and, after a second dilution 1:10 in Tris buffer, incubated on the ELISA plate, serving as a standard curve. After a 4-fold wash in distilled water and once in 0.5% Tween, the plate was incubated with goat anti-human IgG HRP , diluted in PBS þ 0.5% Tween and incubated for 1 h at 37 C. The plate was washed again and 100 mL of substrate containing 0.5 mg/mL o-phenylenediamine and 0.03% H 2 O in a citrate/phosphate buffer at pH 4.9 was added. The plate was then incubated for 10 min on a shaking platform and the reaction was stopped by adding 50 mL of 4 M H 2 SO 4 . Absorbance at 490 nm was read on a spectrophotometer.
Statistics
All statistical analyses were performed with SPSS 19.0 for Windows (IBM, Chicago, IL) and/or GraphPad Prism 5.0. Continuous variables were presented as mean 6 SD or as median and interquartile range (IQR). Categorical variables were presented as percentages. Differences in continuous and categorical variables were checked using, where appropriate, the independent-samples t-or Mann-Whitney U-test and the chisquare or Fisher's exact test, respectively.
R E S U L T S

Patients
Two hundred and twenty-one consecutive patients who underwent renal biopsy between January 1979 and August 2011 were identified as having ANCA-associated glomerulonephritis. Eight of these patients were excluded for concomitant renal disease (six with diabetic nephropathy and two with thin-GBM nephropathy). Furthermore, 17 patients were excluded because the renal biopsy contained less than five glomeruli per slide.
Thus, 196 patients were included in the current study (Table 1) . These patients had a mean age of 61.2 6 14.6, and 29.6% of patients were female. One hundred and two patients were PR3-ANCA positive (52%) and 94 patients were MPO-ANCA positive (48%). Renal biopsies contained 15.1 6 6.5 glomeruli. Overall, 43.2 6 28.4% of glomeruli were normal, 32.7 6 24.3% of glomeruli contained cellular crescents and 8.2 6 10.9% of glomeruli were sclerosed. This translated into 97 patients being classified in the focal group of the AGN classification, 49 patients in the crescentic group, 49 patients in the mixed group and only 1 patient in the sclerotic group. Estimated glomerular filtration rate (eGFR) was 28.7 6 24.7 mL/min and was highest in the focal group, lower in the mixed group and lowest in the crescentic group (focal versus crescentic, P < 0.01; focal versus mixed, P < 0.01; crescentic versus mixed, P ¼ 0.046; Table 1 ). Proteinuria was highest in the mixed group, followed by the crescentic and the focal group (P < 0.01 between all classes; Table 1 ).
Complement
Immunofluorescence (IF) could be performed in 187 patients (95.4%). Differences between AGN classification groups are given in Tables 1 and 2 . Differences between ANCA serotypes are given in Table 3 .
Immunofluorescence. C3c was positive in 40% of focal patients, 55% of crescentic patients and in 40% of mixed patients (P ¼ 0.045; Figure 1A ; Table 2 ), whereas it was positive in 32 PR3-ANCA patients (32.3%) and in 46 MPO-ANCA patients (52.3%; P ¼ 0.006). C1q was positive in 5% of all patients without differences over the AGN groups and/or between ANCA serotypes (P ¼ 0.923 and 0.135, respectively).
Additional IF performed on frozen sections included C4d and C5b-9, the membrane attack complex, properdin and MBL. Renal biopsies were consecutively included between 1 January 2004 and 31 December 2010 with the exclusion of damaged material or insufficient material (n ¼ 25). C4d was present in 34 of 48 renal biopsies and was positive in glomeruli ( Figure 1B ) with no difference between AGN classes or ANCA subtype (Tables 1-3 ). C5b-9 was positive in 38 of 49 renal biopsies without significant differences between the AGN classes or ANCA subtypes (Tables 1-3 ). C5b-9 was observed in a patchy pattern ( Figure 1C ). Properdin was positive in 29 of 75 included biopsies (38.7%; Tables 1-3) and was positive in 27.9% of focal biopsies, 66.7% of crescentic biopsies and 35.7% of mixed biopsies (P ¼ 0.017; Table 1 ). There were no differences for properdin between the ANCA subtypes. The glomerular pattern was usually speckled or granular and always mesangial in addition to its Figure 1D ). Biopsies in which properdin was positive contained more cellular crescents (40.1 6 27.6 versus 26.2 6 25.3%; P ¼ 0.032) and less normal glomeruli (37.2 6 29.4 versus 51.0 6 27.7%; P ¼ 0.026) than biopsies negative for properdin (Figure 2A and B). Patients with a renal biopsy positive for properdin had more proteinuria compared with patients with a renal biopsy negative for properdin, however non-significant (median 0.62 with IQR 0.35-1.61 versus median 1.28 with IQR 0.58-2.21; P ¼ 0.06). MBL was positive in 14 of 46 included biopsies (30.4%) without differences between AGN classes or ANCA subtypes (Tables 1-3) . MBL was always seen in a granular mesangial staining pattern ( Figure 1E) .
Immunohistochemistry. C3d was tested on paraffin sections of renal biopsies (Table 1) Table 4 ). C3d was positive in 24 PR3-ANCA patients (51.1%) and 19 MPO-ANCA patients (70.4%; P ¼ 0.105; Table 3 ). C3d was mainly positive in crescentic lesions or in a mesangiocapillary pattern (Figure 3 ). C3d was also positive in lesions of fibrinoid necrosis (data not shown). Renal biopsies positive for C3d showed more cellular crescents than renal biopsies negative for C3d (P ¼ 0.01; Figure 2C ). Renal biopsies positive for C3d showed a percentage of normal glomeruli of 45.5 6 28.2%, whereas biopsies negative for C3d contained 68.7 6 23.1% normal glomeruli (P < 0.001; Figure 2D ). Also, patients with a renal biopsy positive for C3d had more proteinuria compared with patients with a C3d negative renal biopsy (median: 0.5, IQR: 0.3-1.1 versus median: 1.3, IQR: 0.5-2.5; P ¼ 0.017). Renal biopsies properdin, compared with 20% of biopsies negative for C3d (P ¼ 0.02; Table 4 ). Patients with a renal biopsy positive for C3d had a worse Modification of Diet in Renal Disease at baseline, 1-year follow-up and 2-year follow-up when compared with patients with a renal biopsy negative for C3d (P ¼ 0.006, 0.03 and 0.05, respectively; Supplementary Figure 1) . C3d, properdin and C5b-9 were concurrently positive more often in renal biopsies classified as crescentic or mixed compared with biopsies classified as focal. In other words, the number of positive complement components was higher in crescentic or mixed biopsies compared with focal biopsies (P ¼ 0.007; Figure 4) .
Immunoglobulins
According to the definition of pauci-immunity in AGN (>2þ for any immunoglobulin on a scale of 0-4þ [23] ), 14 out of 187 patients (7.5%) did not have pauci-immune renal biopsies. IgG was positive (trace or 1þ) in 34 patients (18.2%) with five biopsies scoring 2þ, without differences over the AGN groups (P ¼ 0.965). IgG was positive in 11 PR3-ANCA-positive patients (11.1%) and in 23 MPO-ANCA-positive patients (26.1%; P ¼ 0.008). IgA was positive in 22 patients (11.8%) without differences over the AGN groups (P ¼ 0.975), with four biopsies scoring 2þ. IgA was positive in 9 PR3-ANCA patients (9.1%) and in 13 MPO-ANCA patients (14.8%; P ¼ 0.229). IgM was positive in 40% of focal patients and in 23.4% of crescentic and 23.9% of mixed patients (P ¼ 0.056), and it was positive in 34 PR3-ANCA patients (34.3%) and in 27 MPO-ANCA patients (30.7%; P ¼ 0.594). Five biopsies scored 2þ for IgM. None of the biopsies were 2þ positive for IgG and IgA or IgM. j and k were positive in $25% of patients without differences over the AGN groups (P ¼ 0.502 and 0.764, respectively). Fifteen PR3-ANCA patients were positive for j (15.2%), 17 for k (17.2%) compared with 31 (35.2%) and 34 MPO-ANCA patients (38.6%), respectively (P ¼ 0.001 in both j and k).
Electron microscopy
Forty-three biopsies were consecutively included between January 2007 and December 2011. Electron dense deposits were detected in 3 of 43 biopsies (7%). Electron dense deposits in these three renal biopsies were small in size and located mesangially in all three biopsies (<1 lm 2 ; Figure 5A and B). One of these three patients stained positive for IgG upon IF (1þ) and two patients stained positive for IgA upon IF (trace and 1þ). Depositions were seen mesangially in two patients and mesangially and subendothelially in one patient. 
Circulating immune complexes
CICx were measured in patients consecutively included between January 2007 and December 2011 (n ¼ 46). IgG-C3 CICx were undetectable (i.e. below 3 lg/mL) in 32 patients (69.6%). In the remaining 14 patients, mean CICx was 9.6 6 6.3 lg/mL. There was no difference in the concentration of CICx between the AGN classes (P ¼ 0.471) or between ANCA serotypes (P ¼ 0.9; data not shown). There was no relation between CICx and complement components or immunoglobulin deposition in the renal biopsy (data not shown).
C3 allotypes
DNA was available in 92 of 113 patients included between January 2000 and December 2011 (81.4%). Fifty-nine patients were SS (35 PR3-ANCA and 24 MPO-ANCA), 31 patients were FS (20 PR3-ANCA and 11 MPO-ANCA) and 2 patients were FF (both PR3-ANCA). No differences between PR3-ANCA and MPO-ANCA were found with respect to the occurrence of any C3 allotype (Table 3) . No difference was found in C3 allotype distribution over the different AGN classes (Table 1 ). There were also no associations between different C3 allotypes and the deposition of any immunoglobulin or complement component (data not shown).
D I S C U S S I O N
The findings in our study are 3-fold. First, glomerular C3d and C4d stainings, together with a C5b-9 staining, were positive in a found that C3d and properdin were associated with a higher amount of cellular crescents and more proteinuria. This finding was not associated with different C3 allotypes. Third, we could not detect CICx or electron dense deposits in the majority of included patients.
In our study, we analysed components of the classical, lectin and alternative pathways of the complement system in human renal biopsies. In general, staining C3d has the advantage that it reflects complement activation exactly at the location where complement is activated. We found that deposition of C3d was related to the percentage of cellular crescents. C3d was mainly seen at sites of active disease, especially cellular crescentic lesions and lesions of fibrinoid necrosis. C3d was also associated with proteinuria. Our findings are in line with those of Xing et al. [24] who found C3d in fibrocellular crescents in seven MPO-ANCA patients. The deposition or activation of C3 may be influenced by the genetic profile of the gene encoding C3. Persson et al. [20] reported that PR3-ANCA-positive patients were more often of the C3F phenotype compared with MPO-ANCA-positive patients (C3F allele frequencies of 0.32 and 0.20, respectively). We found that in our cohort of patients, PR3-ANCA and MPO-ANCA-positive patients had a similar distribution in C3 phenotype distribution with a C3F allele frequency of 0.21 for PR3-ANCA-positive patients and 0.16 for MPO-ANCA-positive patients. These results are comparable with other studies in which healthy controls had a C3F allele frequency of 0.17-0.20 [20, 25] and renal transplantation patients a C3F allele frequency of 0.21-0.23 [26, 27] . In addition, we found no association between specific C3 phenotypes About 40% of renal biopsies were positive for properdin. This finding is in line with the finding of Gou et al. [8] who found decreased levels of circulating properdin in patients with AAV compared with healthy controls. These decreased properdin levels are probably the result of increased usage of properdin by the alternative pathway.
The presence of properdin in 50% of the biopsies positive for C3d and the association between properdin positivity and cellular crescents point towards activation of the alternative pathway of the complement system in these patients. Consequently, it may be that properdin is used in glomeruli with active lesions, thus leading to the deposition of C3c, C3d and ultimately the formation of C5b-9. Indeed, increased circulating C5b-9 levels were found in AAV when compared with healthy controls [8] .
Several recent studies have shown an important role for the complement system in AAV [6, 9, 28, 29] . Based on observations in experimental models, it is proposed that C5a derived from complement activation causes priming of neutrophils [30] resulting in the release of small amounts of ANCA antigens that are then expressed on the cell surface, where they can interact with ANCA [2] . This interaction results in further neutrophil activation. A factor secreted by activated neutrophils is properdin [31] , which enhances the activation of the alternative pathway of the complement system by stabilizing C3 convertase, mainly by binding to C3b, attached to a cell surface [32] . Also, activated neutrophils and monocytes release proteases and oxidants that can activate complement via the alternative pathway, generating C5a [33] [34] [35] . Otherwise, C5a has been shown to function as a chemoattractant to both neutrophils and monocytes [36] . The increased influx of neutrophils and monocytes-of which the latter differentiate into macrophages on site and may produce and activate complement components as well [37, 38] -may further result in complement activation, effectively establishing a positive feedback amplification [39] .
Importantly, both Huugen et al. [6] and Xiao et al. [9] found that C5 plays a pivotal role in the implication of the complement system in AAV. Xiao et al. [9] found that knocking out C5 in a mouse model resulted in a strong attenuation of glomerulonephritis. In the same study, it was shown that knocking out C4 made no difference but deletion of factor B attenuated disease, implicating a major role for the alternative pathway as opposed to the classical or lectin pathways in the pathophysiology of AAV. Finally, Schreiber et al. [30] demonstrated that C6 knockout mice did develop disease, supporting that not C5b-9 is responsible for glomerulonephritis but C5a. In line with these findings, it was found that blocking C5a or its receptor led to less severe glomerulonephritis [6, 30] . Our data support these studies since the common pathway component C3d, together with the alternative pathway component properdin, is associated with more active cellular crescentic lesions. 
Our data on the classical and lectin pathways are not as straightforward as on the alternative pathway. We found C4d in varying intensities in 70.8% of renal biopsies. C4d was observed in a mesangiocapillary pattern. C4d positive staining in kidney biopsies, depending on the location, has been associated with different renal diseases, such as immune complex-mediated glomerular disease, thrombotic microangiopathy and antibody-mediated rejection [40] . The presence of C4d in glomeruli could point towards an activation of the classical or lectin pathway of the complement system. Xing et al. [24] could not find C4d depositions in renal biopsies from seven AAV patients with MPO-ANCA. Later on, the same group [8] found increased circulating C4d levels in a large group of patients, during active disease as well as during remission, when compared with healthy controls. Also, the same group found C4d depositions in renal biopsies from ANCA negative patients with pauci-immune necrotizing glomerulonephritis [41] .
Importantly, we found MBL deposition only in a minority of patients. This is in line with the study by Xing et al. [24] . This brings us to the question whether the classical pathway is activated, resulting in C4d deposition.
Could immune complexes be the trigger? Haas and Eustace [11] found electron dense deposits in 54% of renal biopsies. In contrast, we found electron dense deposits in only 5% of renal biopsies and these deposits were of small size (<1 lm 2 ), unlike the ones seen, e.g. in IgA nephropathy [22] . Our results are comparable with earlier observations in which renal biopsies from patients with GPA were analysed. In a study by Neumann et al. [12] , electron dense deposits were found in 4 out of 23 patients (17.4%) only. In the studies from Haas and Eustace and Neumann et al., electron dense deposits were seen in renal biopsies positive for IF of C3 and IgG. In our study, all three renal biopsies that contained electron dense deposits also contained C3d with either IgG or IgA.
The formation of electron dense deposits could be a timedependent process, since in an MPO-ANCA rat model, C3 and IgG were detectable in the early course of disease, but undetectable in a later stage [5] . Although we aim to biopsy patients early in the disease course, it could be that immune complexes form very early in the disease course and are cleared once extracapillary cellular proliferation develops [42] .
Also, CICx were undetectable in the majority of included patients. When CICx were detectable, they were found in a low concentration and not related to C4d deposition in the kidney biopsy. CICx have been described in patients with AAV [43, 44] . From these studies, it was concluded that when CICx are found in AAV, they were transient and probably cleared quickly [45] . It is plausible that immune complexes in AAV are formed locally at the vessel wall and are involved in the pathophysiology [4, 42] , possibly in the early course of disease. In our study, however, we could not find immune complexes in the majority of included renal biopsies and we therefore postulate that factors other than immune complexes activate complement in AAV [46, 47] . Future studies need to clarify the source of complement activation resulting in C4d deposition in AAV.
A limitation to our study is that the number of renal biopsies included is relatively small. Our findings therefore need to be confirmed in the future. Also for the future, follow-up renal biopsies from patients who receive anti-C5a receptor blocking treatment should provide interesting results [48] .
In summary, we found complement deposition in a large subgroup of patients with ANCA-associated glomerulonephritis. C3d and properdin were associated with cellular crescents and proteinuria. We found properdin depositions in biopsies positive for C3d, pointing towards activation of the alternative pathway. Furthermore, we found C4d in the majority of renal biopsies, suggesting classical pathway activation as well. Electron dense deposits were found in only 5% of patients, whereas CICx were either present in low concentration or absent. Our findings are therefore compatible with the hypothesis that complement activation in AAV occurs predominantly via alternative pathway activation.
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